Product NewsLife Sciences Leading Drug Discovery Scientists Leverage PathHunter® Arrestin Technology for Discovery of Novel GPCR Drugs
Product NewsLife Sciences DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research
Product NewsDrug discovery > Target Discovery DiscoveRx to Launch PathHunter™ GPCR Explorer Kit for Building On-Demand Functional GPCR Assays at MipTec 2010
Product NewsLife Sciences DiscoveRx PathHunter™ eXpress Kits and GPCR Profiling Services: GPCR Research Made Simple
Product NewsDrug discovery > Lead Discovery High Sensitivity ADP Accumulation Assays for Kinases and ATPases
Product NewsDrug discovery > Lead Discovery Kinase Binding Assays for inactive or low-activity kinases and for determining Structure-Activity Relationships (SAR)
Product NewsDrug discovery > Lead Discovery Custom Kinase Binding Profiling and Labeling Services for SAR and Screening
Product NewsDrug discovery > Lead Discovery PathHunter Technology Webinar: High Biological Context in an HTS Format
Product NewsLife Sciences DiscoveRx, a leader in GPCR assays, launches a 30 second assay for Beta-Arrestin based screening
Product NewsDrug discovery > Lead Discovery DiscoveRx announces a revolutionary application for their PathHunter™ technology platform, winner of the 2006 Frost & Sullivan Technology Innovation Award
Product NewsDrug discovery > Target Discovery DiscoveRx PathHunter™ Technology Successfully Implemented in NIH Roadmap Initiative
Product NewsLife Sciences DiscoveRx Launches ß-arrestin Assay Platform for High Throughput GPCR Screening
Product NewsDrug discovery > Target Discovery DiscoveRx Enters into Custom Labeling and Profiling Services for Kinases and Proteases
Product NewsLife Sciences "DiscoveRx Expands PathHunter™ Portfolio with Release of Homogeneous Mitotic Index Assays"
